PAPER Graeber MB, Kösel S, Grasbon-Frodl E, Möller HJ, Mehraein P
SEARCH RESULTS
331256 RESULTS
PAPER Graeber MB, Kösel S, Egensperger R, Banati RB, Müller U, Bise K, Hoff P, Möller HJ, Fujisawa K, Mehraein P
Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis.
Neurogenetics. 1997 May;1(1):73-80. PubMed: 10735278PAPER Bird TD, Lampe TH, Nemens EJ, Miner GW, Sumi SM, Schellenberg GD
Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect.
Ann Neurol. 1988 Jan;23(1):25-31. PubMed: 3345066Kenneth Kosik on NIH Calls for More (and Different) Research on Preventive Measures
COMMENT The NIH State-of-the-Science Conference has set a threshold of evidence required to make recommendations that goes beyond what would best serve the interests of public health. This may seem paradoxical, because as scientists we demand the highest standard
Andrew Malinow
United States
Marshal Folstein
Tufts, Johns HopkinsMiami Beach, United States
PAPER Jose A, Krishnan LK
Effect of matrix composition on differentiation of nestin-positive neural progenitors from circulation into neurons.
J Neural Eng. 2010 Jun;7(3):036009. PubMed: 20479522Research Brief: Auguste D.'s Mutation Identified?
RESEARCH NEWS 2010-05-20 Research News Writing the latest pages of an anthropological mystery, scientists propose in this month’s Archives of Neurology that it is highly possible that Auguste Deter, the first identified Alzheimer disease patient, carried the N141I presenilin-2 mu
PAPER Chang LK, Zhao JH, Liu HL, Wu JW, Chuang CK, Liu KT, Chen JT, Tsai WB, Ho Y
The importance of steric zipper on the aggregation of the MVGGVV peptide derived from the amyloid beta peptide.
J Biomol Struct Dyn. 2010 Aug;28(1):39-50. PubMed: 20476794PAPER
Biomarkers may help predict risk of Alzheimer's disease.
J Inherit Metab Dis. 2010 Jun 8; PubMed: 20477523PAPER Ereshefsky L, Jhee S, Yen M, Moran S, Pretorius S, Adams J
Cerebrospinal fluid beta-amyloid and dynabridging in Alzheimer's disease drug development.
Biomark Med. 2009 Dec;3(6):711-21. PubMed: 20477709PAPER Mattsson N, Zetterberg H
Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications.
Biomark Med. 2009 Dec;3(6):735-7. PubMed: 20477711PAPER Juréus A, Swahn BM, Sandell J, Jeppsson F, Johnson AE, Johnström P, Neelissen JA, Sunnemark D, Farde L, Svensson SP
Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
J Neurochem. 2010 Aug;114(3):784-94. PubMed: 20477945PAPER Hughes M, Snetkov V, Rose RS, Trousil S, Mermoud JE, Dingwall C
Neurite-like structures induced by mevalonate pathway blockade are due to the stability of cell adhesion foci and are enhanced by the presence of APP.
J Neurochem. 2010 Aug;114(3):832-42. PubMed: 20477946PAPER Yu C, Nwabuisi-Heath E, Laxton K, LaDu MJ
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.
Mol Neurodegener. 2010;5:19. PubMed: 20478062Current Filters
No filters selected